Permanently Discontinued

MAEVE

GLENMARK PHARMACEUTICALS CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MAEVE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MAEVE 0.35MG has been permanently discontinued (last updated October 27, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MAEVE not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file3 products

Affected strength0.35MG

Report last updated2026-10-27

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MOVISSE

SENADOR LABORATORIES PRIVATE LIMITED

0.35MG · DIN 02410303

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

JENCYCLA

LUPIN PHARMA CANADA LIMITED

0.35MG · DIN 02441306

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

NORLUTATE

SEARCHLIGHT PHARMA INC

5MG · DIN 00023760

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02458683

Strength

0.35MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

NORETHINDRONE

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

MAEVE has 2 shortage/discontinuation reports on file — this is one of them.

2026-09-29

Active Shortage

Disruption of the manufacture of the drug.

Other Products from GLENMARK PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

DIN 02466783

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP

DIN 02462060

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21

DIN 02421437

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28

DIN 02421445

GLN-APREMILAST

30MG · DIN 02518910

GLN-ATOVAQUONE

750MG · DIN 02528495